Clinical Trial Update: Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA)

View source ↗

Summary

A completed clinical trial evaluating bronchial inflammation in Allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis
• Cystic Fibrosis

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Cystic Fibrosis, | Status: COMPLETED